By integrating these advancements into routine practice, Ki-67 assessment not only remains a cornerstone of tumour biology but also evolves to meet the demands of precision medicine, ultimately improving diagnostic accuracy and patient outcomes. This evidence concerns the gene MKI67 and neoplasm.